Safety and efficacy of endovascular treatment for intracranial infectious aneurysms: A systematic review and meta-analysis

Journal of Neuroradiology

Volumn 43, Issue 5, 2016, Pages 309-316

  Petr, Ondra ^a,b,c   Brinjikji, Waleed ^a   Burrows, Anthony M ^a   Cloft, Harry ^a   Kallmes, David F ^a   Lanzino, Giuseppe ^a  

^a MAYO CLINIC   (United States)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Endovascular treatment; Intracranial infectious aneurysms (IIAs); Meta analysis; Mycotic

Indexed keywords

GLUE; ONYX COPOLYMER;

ANEURYSM RUPTURE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COIL EMBOLIZATION; COMORBIDITY; ENDOVASCULAR TREATMENT; GLASGOW OUTCOME SCALE; HUMAN; INTRACRANIAL ANEURYSM; INTRACRANIAL INFECTIOUS ANEURYSM; META ANALYSIS; MORTALITY RATE; MYCOTIC ANEURYSM; NEUROLOGIC DISEASE; NONSURGICAL INVASIVE THERAPY; RANKIN SCALE; RECURRENCE RISK; REVIEW; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; ADULT; ADVERSE EFFECTS; AGED; ENDOVASCULAR SURGERY; FEMALE; MALE; MIDDLE AGED; MORTALITY; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84964644474     PISSN: 01509861     EISSN: 17730406     Source Type: Journal    
DOI: 10.1016/j.neurad.2016.03.008     Document Type: Review

References (32)

1. [1] Nakahara, I., Taha, M.M., Higashi, T., Iwamuro, Y., Iwaasa, M., Watanabe, Y., et al. Different modalities of treatment of intracranial mycotic aneurysms: report of 4 cases. Surg Neurol 66:4 (2006), 405–409 [discussion 9–10].
2. [2] Ducruet, A.F., Hickman, Z.L., Zacharia, B.E., Narula, R., Grobelny, B.T., Gorski, J., et al. Intracranial infectious aneurysms: a comprehensive review. Neurosurg Rev 33:1 (2010), 37–46.
3. [3] Chapot, R., Houdart, E., Saint-Maurice, J.P., Aymard, A., Mounayer, C., Lot, G., et al. Endovascular treatment of cerebral mycotic aneurysms. Radiology 222:2 (2002), 389–396.
4. [4] Chun, J.Y., Smith, W., Halbach, V.V., Higashida, R.T., Wilson, C.B., Lawton, M.T., Current multimodality management of infectious intracranial aneurysms. Neurosurgery 48:6 (2001), 1203–1213 [discussion 13–4].
5. [5] Phuong, L.K., Link, M., Wijdicks, E., Management of intracranial infectious aneurysms: a series of 16 cases. Neurosurgery 51:5 (2002), 1145–1151.
6. [6] Mine, B., Pezzullo, M., Roque, G., David, P., Metens, T., Lubicz, B., Detection and characterization of unruptured intracranial aneurysms: comparison of 3T MRA and DSA. J Neuroradiol 42:3 (2015), 162–168.
7. [7] Berge, J., Blanco, P., Rooryck, C., Boursier, R., Marnat, G., Gariel, F., et al. Understanding flow patterns and inflammatory status in intracranial aneurysms: towards a personalized medicine. J Neuroradiol 43:2 (2016), 141–147.
8. [8] Erdogan, H.B., Erentug, V., Bozbuga, N., Goksedef, D., Akinci, E., Yakut, C., Endovascular treatment of intracerebral mycotic aneurysm before surgical treatment of infective endocarditis. Tex Heart Inst J 31:2 (2004), 165–167.
9. [9] Eddleman, C., Nikas, D., Shaibani, A., Khan, P., Dipatri, A.J. Jr., Tomita, T., HydroCoil embolization of a ruptured infectious aneurysm in a pediatric patient: case report and review of the literature. Childs Nerv Syst 23:6 (2007), 707–712.
10. [10] DerSimonian, R., Laird, N., Meta-analysis in clinical trials. Control Clin Trials 7:3 (1986), 177–188.
11. [11] Altman, D.G., Bland, J.M., Interaction revisited: the difference between two estimates. BMJ, 326(7382), 2003, 219.
12. [12] Higgins, J.P., Thompson, S.G., Quantifying heterogeneity in a meta-analysis. Stat Med 21:11 (2002), 1539–1558.
13. [13] Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327:7414 (2003), 557–560.
14. [14] Peters, P.J., Harrison, T., Lennox, J.L., A dangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis. Lancet Infect Dis 6:11 (2006), 742–748.
15. [15] Zanaty, M., Chalouhi, N., Starke, R.M., Tjoumakaris, S., Gonzalez, L.F., Hasan, D., et al. Endovascular treatment of cerebral mycotic aneurysm: a review of the literature and single center experience. Biomed Res Int, 2013, 2013, 151643.
16. [16] Eddleman, C.S., Surdell, D., DiPatri, A. Jr., Tomita, T., Shaibani, A., Infectious intracranial aneurysms in the pediatric population: endovascular treatment with Onyx. Childs Nerv Syst 24:8 (2008), 909–915.
17. [17] Bartakke, S., Kabde, U., Muranjan, M.N., Bavdekar, S.B., Mycotic aneurysm: an uncommon cause for intra-cranial hemorrhage. Indian J Pediatr 69:10 (2002), 905–907.
18. [18] Bohmfalk, G.L., Story, J.L., Wissinger, J.P., Brown, W.E. Jr., Bacterial intracranial aneurysm. J Neurosurg 48:3 (1978), 369–382.
19. [19] Frazee, J.G., Cahan, L.D., Winter, J., Bacterial intracranial aneurysms. J Neurosurg 53:5 (1980), 633–641.
20. [20] Lerner, P.I., Neurologic complications of infective endocarditis. Med Clin North Am 69:2 (1985), 385–398.
21. [21] Monsuez, J.J., Vittecoq, D., Rosenbaum, A., Goujon, C., Wolff, M., Witchitz, S., et al. Prognosis of ruptured intracranial mycotic aneurysms: a review of 12 cases. Eur Heart J 10:9 (1989), 821–825.
22. [22] Koch, P., Desal, H.A., Auffray-Calvier, E., De Kersaint-Gilly, A., [Natural history and management of mycotic intracranial aneurysm]. J Neuroradiol 32:4 (2005), 258–265.
23. [23] Kannoth, S., Thomas, S.V., Intracranial microbial aneurysm (infectious aneurysm): current options for diagnosis and management. Neurocrit Care 11:1 (2009), 120–129.
24. [24] Khayata, M.H., Aymard, A., Casasco, A., Herbreteau, D., Woimant, F., Merland, J.J., Selective endovascular techniques in the treatment of cerebral mycotic aneurysms. Report of three cases. J Neurosurg 78:4 (1993), 661–665.
25. [25] Scotti, G., Li, M.H., Righi, C., Simionato, F., Rocca, A., Endovascular treatment of bacterial intracranial aneurysms. Neuroradiology 38:2 (1996), 186–189.
26. [26] Fortes, C.Q., Wajnberg, E., Potsh, D.V., Moreira, R.B., Espanha, C.A., Garcia, M.I., et al. Endovascular treatment of mycotic intracranial aneurysms: report of four cases. Clin Res Cardiol 96:6 (2007), 454–455.
27. [27] Dhomne, S., Rao, C., Shrivastava, M., Sidhartha, W., Limaye, U., Endovascular management of ruptured cerebral mycotic aneurysms. Br J Neurosurg 22:1 (2008), 46–52.
28. [28] Wajnberg, E., Rueda, F., Marchiori, E., Gasparetto, E.L., Endovascular treatment for intracranial infectious aneurysms. Arq Neuropsiquiatr 66:4 (2008), 790–794.
29. [29] Chalouhi, N., Tjoumakaris, S., Gonzalez, L.F., Hasan, D., Alkhalili, K., Dumont, A.S., et al. Endovascular treatment of distal intracranial aneurysms with Onyx 18/34. Clin Neurol Neurosurg 115:12 (2013), 2528–2532.
30. [30] Grandhi, R., Zwagerman, N.T., Linares, G., Monaco, E.A. 3rd., Jovin, T., Horowitz, M., et al. Onyx embolization of infectious intracranial aneurysms. J Neurointerv Surg 6:5 (2014), 353–356.
31. [31] Ahmed, A.Z., Meshaal, M.S., Kassem, H.H., Role of cerebral CTA screening on treatment planning and outcome in patients with left sided infective endocarditis. Egypt J Radiol Nucl Med 46:1 (2015), 117–123.
32. [32] Matsubara, N., Miyachi, S., Izumi, T., Yamanouchi, T., Asai, T., Ota, K., et al. Results and current trends of multimodality treatment for infectious intracranial aneurysms. Neurol Med Chir (Tokyo) 55:2 (2015), 155–162.